SAM
ACAD icon

Sectoral Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Sectoral Asset Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-15,060
Closed -$472K – 93
2023
Q4 		$472K Sell
15,060
-194,900
-93% -$4.65M 0.2% 80
2023
Q3 		$4.38M Buy
+209,960
New +$5.7M 0.85% 51
2021
Q1 		– Sell
-654,414
Closed -$35M – 114
2020
Q4 		$35M Buy
654,414
+97,900
+18% +$4.86M 2.47% 11
2020
Q3 		$23M Buy
556,514
+213,851
+62% +$9.23M 1.97% 16
2020
Q2 		$16.6M Buy
342,663
+105,213
+44% +$5.05M 1.52% 24
2020
Q1 		$10M Buy
237,450
+93,000
+64% +$3.83M 1.93% 18
2019
Q4 		$6.18M Buy
+144,450
New +$6.28M 0.92% 44
2018
Q2 		– Sell
-783,424
Closed -$17.6M – 68
2018
Q1 		$17.6M Sell
783,424
-348,298
-31% -$9.64M 1.93% 20
2017
Q4 		$34.1M Buy
1,131,722
+309,330
+38% +$9.89M 4.26% 3
2017
Q3 		$31M Sell
822,392
-276,417
-25% -$8.99M 3.99% 4
2017
Q2 		$30.6M Buy
1,098,809
+427,696
+64% +$12.7M 3.35% 9
2017
Q1 		$23.1M Sell
671,113
-505,430
-43% -$17.8M 2.69% 18
2016
Q4 		$33.9M Buy
1,176,543
+1,120,646
+2,005% +$29.6M 3.76% 6
2016
Q3 		$1.78M Buy
55,897
+26,315
+89% +$892K 0.17% 52
2016
Q2 		$960K Sell
29,582
-661,118
-96% -$22.1M 0.1% 60
2016
Q1 		$19.3M Buy
+690,700
New +$15.1M 0.93% 31

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sectoral Asset Management's ACAD Position: Q1 2024 in Review

Sectoral Asset Management sold out of Acadia Pharmaceuticals (ACAD) in Q1 2024, closing a stake of 15,060 shares — an estimated $472K sold.

Sectoral Asset Management first reported a position in ACAD in Q1 2016 and held it in 16 quarters. The position peaked at $35M in Q4 2020. 267 funds tracked by Wall St. Rank hold ACAD as of Q1 2024.

  • Sectoral Asset Management reported no remaining Acadia Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Sectoral Asset Management sold 15,060 Acadia Pharmaceuticals shares in Q1 2024, an estimated $472K.
  • Sectoral Asset Management first reported a position in Acadia Pharmaceuticals in Q1 2016 and held it in 16 quarters.
  • Sectoral Asset Management's Acadia Pharmaceuticals position peaked at $35M in Q4 2020.
  • 267 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2024.

Based on Sectoral Asset Management's 13F filing for Q1 2024, filed 14 May 2024.